BCRX

BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)

About BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Details

Daily high

$8.23

Daily low

$8.02

Price at open

$8.19

52 Week High

$11.22

52 Week Low

$6.00

Market cap

2.1B

Dividend yield

Volume

6.1M

Avg. volume

3.5M

P/E ratio

-5.47

BioCryst Pharmaceuticals, Inc. - Common Stock News